Investigating a Self-Care Model for Patients with Prostate Cancer
Research type
Research Study
Full title
Investigating an Innovative Self-Care Model for Patients with Prostate Cancer
IRAS ID
161536
Contact name
Stuart McCracken
Contact email
Sponsor organisation
Newcastle Joint Research Office
Duration of Study in the UK
0 years, 6 months, 1 days
Research summary
The high incidence and survival rates for prostate cancer are leading to overburdened follow-up which is lacking in individualised care. There is an urgent need for an effective new model which integrates “well survivors” back into the community, providing cost-effective support. The main objective/hypothesis of the proposed research is to assess if prostate cancer patients on androgen deprivation therapy (ADT) can be monitored and managed remotely, with quantifiable benefits to their quality of life, and also with significant cost-effectiveness. In order to do this an acceptable, reliable and rapid "home test" for PSA will be needed, which could be linked to mobile communication to report values to the clinic and to perhaps instruct patients to amend their treatment dose or schedule an appointment to attend a clinic. Such a “home test” does not exist at this time. This will be achieved by adaptation of a near-to-market technology from OJ-Bio which would be provided for testing and evaluation. Testing would require adapting the OJ-Bio system to measure PSA and also to compare its analytical performance with standard tests in the hospital diagnostic laboratory. Patient acceptability studies are also an important part of this research proposal as we attempt to progress to EC Horizon 2020 programme funding, facilitating a European-wide study of a home-monitoring and management sensor system, with communication capacities, for prostate cancer patients treated by hormone therapy.
REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
15/NE/0243
Date of REC Opinion
28 Apr 2016
REC opinion
Further Information Favourable Opinion